Repligen Corporation (RGEN) - Total Liabilities
Based on the latest financial reports, Repligen Corporation (RGEN) has total liabilities worth $838.15 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Repligen Corporation's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Repligen Corporation - Total Liabilities Trend (1985–2025)
This chart illustrates how Repligen Corporation's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Repligen Corporation asset portfolio.
Repligen Corporation Competitors by Total Liabilities
The table below lists competitors of Repligen Corporation ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Discovery Holdings Ltd
JSE:DSY
|
South Africa | ZAC261.75 Billion |
|
Petro Rio S.A.
SA:PRIO3
|
Brazil | R$36.48 Billion |
|
Sejahteraraya Anugrahjaya Tbk
JK:SRAJ
|
Indonesia | Rp6.19 Trillion |
|
Chart Industries Inc
NYSE:GTLS
|
USA | $6.42 Billion |
|
Toro Co
NYSE:TTC
|
USA | $2.28 Billion |
|
Jinduicheng Molybdenum Co Ltd
SHG:601958
|
China | CN¥2.88 Billion |
|
Aptiv PLC
NYSE:APTV
|
USA | $9.24 Billion |
|
ORIENT OVERSEAS INT.ADR/5
F:ORI
|
Germany | €4.26 Billion |
Liability Composition Analysis (1985–2025)
This chart breaks down Repligen Corporation's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Repligen Corporation (RGEN) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 9.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Repligen Corporation's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Repligen Corporation (1985–2025)
The table below shows the annual total liabilities of Repligen Corporation from 1985 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $843.57 Million | -1.56% |
| 2024-12-31 | $856.95 Million | +0.44% |
| 2023-12-31 | $853.21 Million | +37.41% |
| 2022-12-31 | $620.90 Million | +2.07% |
| 2021-12-31 | $608.29 Million | +62.76% |
| 2020-12-31 | $373.74 Million | +9.81% |
| 2019-12-31 | $340.35 Million | +113.98% |
| 2018-12-31 | $159.05 Million | +4.70% |
| 2017-12-31 | $151.92 Million | +26.44% |
| 2016-12-31 | $120.15 Million | +411.51% |
| 2015-12-31 | $23.49 Million | +41.83% |
| 2014-12-31 | $16.56 Million | +12.21% |
| 2013-12-31 | $14.76 Million | +14.54% |
| 2012-12-31 | $12.89 Million | +27.58% |
| 2011-12-31 | $10.10 Million | +93.96% |
| 2010-12-31 | $5.21 Million | 0.00% |
| 2009-12-31 | $5.21 Million | -1.74% |
| 2008-12-31 | $5.30 Million | +14.43% |
| 2007-12-31 | $4.63 Million | -2.15% |
| 2006-12-31 | $4.73 Million | +33.79% |
| 2005-12-31 | $3.54 Million | +11.73% |
| 2004-12-31 | $3.17 Million | -4.56% |
| 2003-12-31 | $3.32 Million | +18.17% |
| 2002-12-31 | $2.81 Million | +25.14% |
| 2001-12-31 | $2.24 Million | -15.88% |
| 2000-12-31 | $2.67 Million | +112.18% |
| 1999-12-31 | $1.26 Million | +4.99% |
| 1998-12-31 | $1.20 Million | +199.27% |
| 1997-12-31 | $400.00K | +33.33% |
| 1996-12-31 | $300.00K | -62.50% |
| 1995-12-31 | $800.00K | -94.90% |
| 1994-12-31 | $15.70 Million | +23.62% |
| 1993-12-31 | $12.70 Million | +4.10% |
| 1992-12-31 | $12.20 Million | +64.86% |
| 1991-12-31 | $7.40 Million | +164.29% |
| 1990-12-31 | $2.80 Million | +7.69% |
| 1989-12-31 | $2.60 Million | -23.53% |
| 1988-12-31 | $3.40 Million | +21.43% |
| 1987-12-31 | $2.80 Million | +12.00% |
| 1986-12-31 | $2.50 Million | +38.89% |
| 1985-12-31 | $1.80 Million | -- |
About Repligen Corporation
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, … Read more